Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-28

FDA Approved: MESALAMINE — Supplemental Application (Northstar Rx LLC.)

View source ↗

Summary

The FDA approved a supplemental application for Mesalamine submitted by Northstar Rx LLC (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

SUPPL AP for MESALAMINE (MESALAMINE)